1. Home
  2. GLMD vs GV Comparison

GLMD vs GV Comparison

Compare GLMD & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • GV
  • Stock Information
  • Founded
  • GLMD 2000
  • GV 2013
  • Country
  • GLMD Israel
  • GV Canada
  • Employees
  • GLMD N/A
  • GV N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • GLMD Health Care
  • GV Real Estate
  • Exchange
  • GLMD Nasdaq
  • GV Nasdaq
  • Market Cap
  • GLMD 8.0M
  • GV 6.8M
  • IPO Year
  • GLMD 2014
  • GV 2022
  • Fundamental
  • Price
  • GLMD $1.59
  • GV $1.91
  • Analyst Decision
  • GLMD Hold
  • GV
  • Analyst Count
  • GLMD 1
  • GV 0
  • Target Price
  • GLMD N/A
  • GV N/A
  • AVG Volume (30 Days)
  • GLMD 81.5K
  • GV 5.1M
  • Earning Date
  • GLMD 11-13-2025
  • GV 10-21-2025
  • Dividend Yield
  • GLMD N/A
  • GV N/A
  • EPS Growth
  • GLMD N/A
  • GV N/A
  • EPS
  • GLMD N/A
  • GV N/A
  • Revenue
  • GLMD N/A
  • GV $7,773,905.00
  • Revenue This Year
  • GLMD N/A
  • GV N/A
  • Revenue Next Year
  • GLMD N/A
  • GV N/A
  • P/E Ratio
  • GLMD N/A
  • GV N/A
  • Revenue Growth
  • GLMD N/A
  • GV N/A
  • 52 Week Low
  • GLMD $1.15
  • GV $1.00
  • 52 Week High
  • GLMD $4.81
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 58.87
  • GV 49.58
  • Support Level
  • GLMD $1.35
  • GV $2.00
  • Resistance Level
  • GLMD $1.63
  • GV $2.17
  • Average True Range (ATR)
  • GLMD 0.09
  • GV 0.23
  • MACD
  • GLMD 0.02
  • GV -0.02
  • Stochastic Oscillator
  • GLMD 76.67
  • GV 5.56

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: